Fact CheckerSign in

NCT04146428Completed

Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

Research teams in Boston University, UCLA, and Weill Cornell will recruit 90 participants in 3 years (10 participants per site per year) and evaluate JASPER, play-based intervention, using the BOSCC and ELSA-T. Participants will be randomized to receive JASPER facilitated either by a clinician or the caregiver. After 10 weeks, the participants will be evaluated using the CGI to determine if they are "responders" or "non-responders". Nonresponders will be given a mix of clinician and caregiver-facilitated JASPER and responders will remain the course for the following 10 weeks. Coding of the BOSCC and ELSA-T will be the outcome measures and change will be evaluated throughout the study.

Status (registry)
Completed
Study type
Interventional
Enrollment
84 (actual)
First submitted
29 Oct 2019
Start date
27 Apr 2021
Primary completion date
14 May 2025
Lead sponsor
University of California, Los Angeles
Diseases
Autism
NCT number
NCT04146428

What you commit to

  • Study type: Interventional
  • Participants enrolled: 84
  • From 27 Apr 2021 to the primary completion date, 14 May 2025
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Children that do not have a mental age greater than or equal to 12 months, don't have a confirmed diagnosis, are under the age of 18 months and older than 5 years of age.

Who the study is looking for

  • Minimally verbal children eligible for the ADOS Toddler Module or Module 1 (pre or minimally verbal) or those who have emerging phrases who may receive Module 2 (phrase speech) will be enrolled. The sample will be limited to children with confirmed diagnosis and nonverbal mental ages greater than or equal to 12 months. The child must be 18 months and 5 years of age.

Age in the registry: 18 months to 5 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Boston University
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
UCLA
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Semel Institute
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
Weill Cornell Medical College/New York Presbyterian Hospital
Coordinator of this site? Confirm its status
White PlainsUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.